These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 11216977

  • 1. Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrequent, well-tolerated paroxysmal supraventricular tachycardia.
    Alboni P, Tomasi C, Menozzi C, Bottoni N, Paparella N, Fucà G, Brignole M, Cappato R.
    J Am Coll Cardiol; 2001 Feb; 37(2):548-53. PubMed ID: 11216977
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Flecainide and sotalol: a new combination therapy for refractory supraventricular tachycardia in children <1 year of age.
    Price JF, Kertesz NJ, Snyder CS, Friedman RA, Fenrich AL.
    J Am Coll Cardiol; 2002 Feb 06; 39(3):517-20. PubMed ID: 11823091
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of low-dose propranolol versus diltiazem in the prophylaxis of supraventricular tachyarrhythmia after coronary artery bypass grafting.
    Babin-Ebell J, Keith PR, Elert O.
    Eur J Cardiothorac Surg; 1996 Feb 06; 10(6):412-6. PubMed ID: 8817135
    [Abstract] [Full Text] [Related]

  • 6. Oral flecainide, sotalol, and verapamil for the termination of paroxysmal supraventricular tachycardia.
    Hamer AW, Strathmore N, Vohra JK, Hunt VD.
    Pacing Clin Electrophysiol; 1993 Jul 06; 16(7 Pt 1):1394-400. PubMed ID: 7689205
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
    Hopson JR, Buxton AE, Rinkenberger RL, Nademanee K, Heilman JM, Kienzle MG.
    Am J Cardiol; 1996 Jan 25; 77(3):72A-82A. PubMed ID: 8607395
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Termination of paroxysmal supraventricular tachycardia with a single oral dose of diltiazem and propranolol.
    Yeh SJ, Lin FC, Chou YY, Hung JS, Wu D.
    Circulation; 1985 Jan 25; 71(1):104-9. PubMed ID: 3964710
    [Abstract] [Full Text] [Related]

  • 13. The use of flecainide in critical neonates and infants with incessant supraventricular tachycardias.
    Ergül Y, Özyılmaz İ, Saygı M, Tola HT, Akdeniz C, Tuzcu V.
    Turk Kardiyol Dern Ars; 2015 Oct 25; 43(7):607-12. PubMed ID: 26536985
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia.
    Gambhir DS, Bhargava M, Arora R, Khalilullah M.
    Indian Heart J; 1995 Oct 25; 47(3):237-43. PubMed ID: 7558090
    [Abstract] [Full Text] [Related]

  • 20. Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach.
    Alboni P, Botto GL, Baldi N, Luzi M, Russo V, Gianfranchi L, Marchi P, Calzolari M, Solano A, Baroffio R, Gaggioli G.
    N Engl J Med; 2004 Dec 02; 351(23):2384-91. PubMed ID: 15575054
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.